Literature DB >> 3340441

Taurine and osmoregulation: taurine is a cerebral osmoprotective molecule in chronic hypernatremic dehydration.

H Trachtman1, R Barbour, J A Sturman, L Finberg.   

Abstract

We studied the effect of 8-wk dietary taurine depletion on the vulnerability to hypernatremic dehydration in postweanling kittens. While experimental taurine depletion was not associated with increased susceptibility to acute hypernatremia (1.5 M NaCl/NaHCO3, 35 ml/kg body weight, single injection), there was an increase in mortality (five of seven versus one of seven, p = 0.05) and seizure activity (three of seven versus none of seven, p = 0.08) in taurine-depleted compared to taurine-replete kittens rendered chronically hypernatremic over 96 h. Furthermore, there was a significant decrease in brain cell water (517.4 +/- 21.7 versus 671.6 +/- 32.3 ml/100 g fat-free dry weight, p less than 0.05), derived almost exclusively from the intracellular compartment (352.5 +/- 12.3 versus 483.8 +/- 34.6 ml/100 g fat-free dry weight, p less than 0.05) that correlated with the reduction in the cerebral taurine content in the taurine-depleted versus control kittens during chronic hypernatremic dehydration. These results suggest that taurine is an important cerebral osmoprotective molecule. This aminoacid constitutes nearly 50% of the adaptable intracellular osmolal pool whose concentration varies in the course of osmoregulating in response to perturbations in the extracellular fluid tonicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340441     DOI: 10.1203/00006450-198801000-00008

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  20 in total

1.  Brain apparent diffusion coefficient decrease during correction of severe hypernatremic dehydration.

Authors:  Andrea Righini; Luca Ramenghi; Salvatore Zirpoli; Fabio Mosca; Fabio Triulzi
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

2.  Taurine: A therapeutic agent in experimental kidney disease.

Authors:  H Trachtman; J A Sturman
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

Review 3.  Volume regulation in brain cells: cellular and molecular mechanisms.

Authors:  H Pasantes-Morales
Journal:  Metab Brain Dis       Date:  1996-09       Impact factor: 3.584

4.  Effects of taurine on cell morphology and expression of low-affinity GABA receptors in cultured cerebellar granule cells.

Authors:  J H Abraham; A Schousboe
Journal:  Neurochem Res       Date:  1989-10       Impact factor: 3.996

5.  Taurine as osmoregulator and neuromodulator in the brain.

Authors:  S S Oja; P Saransaari
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

6.  Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis.

Authors:  Y H Lien; J I Shapiro; L Chan
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 7.  Taurine and the renal system.

Authors:  Russell W Chesney; Xiaobin Han; Andrea B Patters
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 8.  The osmotic/calcium stress theory of brain damage: are free radicals involved?

Authors:  T L Pazdernik; M Layton; S R Nelson; F E Samson
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

Review 9.  Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II.

Authors:  H Trachtman
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

10.  Taurine in toad brain and blood under different conditions of osmolality: an immunohistochemical study.

Authors:  C F Baxter; R A Baldwin; P Lu; H Imaki; J A Sturman
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.